Among these, the detection of IKZF1 deletion, associated with the worse B-ALL prognosis, especially if combined with the presence of the BCR-ABL1 fusion gene [32], has been a challenge due to IKZF1 deletion heterogeneity. The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.